Clinical benefits versus shortcomings of diltiazem once-daily in the chronotherapy of cardiovascular diseases

Bibliography

• Muller JE, Stone PH, Turi ZG, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985;313:1315-22
   PubMed Web of Science ®Google Scholar
• Willich SN, Linderer T, Wegscheider K, et al. Absence with prior β-adrenergic blockade. Circulation 1989;80:853-8
   PubMed Web of Science ®Google Scholar
• Willich SN, Levy D, Rocco MB, et al. Circadian variation in the incidence of sudden cardiac death in the Framingham heart study population. Am J Cardiol 1987;60:801-6
   PubMed Web of Science ®Google Scholar
• Anderson LT, Sigurd B, Hansen JF. Verapamil and circadian variation of sudden death. Am Heart J 1996;131:409-10
   PubMed Web of Science ®Google Scholar
• Rocco MB, Barry J, Campbell S, et al. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 1987;75:395-400
   PubMed Web of Science ®Google Scholar
• Willich AN, Lowel H, Lewis M, et al. Association of wake time and the onset of myocardial infarction. Circulation 1991;84(Suppl 6):V162-7
   Web of Science ®Google Scholar
• Kearney PM, Whelton M, Reynolds K, et al. Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group 2004;22:11-9
   Google Scholar
• Weber MA, Drayer JI, Nakamura DK, Wyle FA. The circadian blood pressure pattern in ambulatory normal subjects. Am J Cardiol 1984;54:115-9
   PubMed Web of Science ®Google Scholar
• Muller JE, Ludmer PL, Willich SN, et al. Circadian variation in the frequency of sudden cardiac death. Circulation 1987;75:131-8
   PubMed Web of Science ®Google Scholar
• Willich SN, Linderer T, Wegscheider K, et al. Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group. Circulation 1989;80(4):853-8
   PubMed Web of Science ®Google Scholar
• Hausmann D, Lichtlen PR, Nikutta P, et al. Circadian variation of myocardial ischemia in patients with stable coronary artery disease. Chronbiol Int 1991;8(5):385-98
   PubMed Web of Science ®Google Scholar
• Marler JR, Price TR, Clark GL, et al. Morning increase in onset of ischemic stroke. Stroke 1989;20(4):473-6
   PubMed Web of Science ®Google Scholar
• Willich SN, Levy D, Rocco MB, et al. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol 1987;60(10):801-6
   PubMed Web of Science ®Google Scholar
• Tofler GH, Brezinski D, Schafer AI, et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987;316(24):1514-8
   PubMed Web of Science ®Google Scholar
• Nademanee K, Intarachot V, Josephson MA, Singh BN. Circadian variation in occurrence of transient overt and silent myocardial ischemia in chronic stable angina and comparison with Prinzmetal angina in men. Am J Cardiol 1987;60(7):494-8
   PubMed Web of Science ®Google Scholar
• Glasser SP, Claas SA. Long-acting Diltiazem HCl for the chronotherapeutic treatment of hypertension and chronic stable angina pectoris. Expert Opin Pharmacother 2005;6(5):1-4
   PubMed Web of Science ®Google Scholar
• Elliot WJ. Cyclic and Circadian Variations in Cardiovascular Events. Am J Hypertens 2001;14:291S-5S
   PubMedGoogle Scholar
• Kario K, Pickering TG, et al. Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly Hypertensives: A Prospective Study. Circulation 2003;107:1401-6
   PubMed Web of Science ®Google Scholar
• Facts about Cardiovascular Diseases: CDC-OC-WrongDiagnosis.com Available from: http://www.wrongdiagnosis.com/artic/facts_about_cardiovascular_disease_cdc_oc.htm
   Google Scholar
• Albert Figueras, Joan-Ramon Laporte. Failures of therapeutic chain as a cause of drug ineffectiveness. BMJ 2003;326(7395):895-96
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Calvo C, et al. Effects of the time of day on ambulatory blood pressure pattern of patients with resitent hypertension. Hypertens 2005;46:1053-59
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, et al. Decrease in urinary albumin excretion associated with normalization of nocturnal blood pressure in hypertensive subjects. Hypertens 2005;46:960-68
   PubMed Web of Science ®Google Scholar
• Chalmers J, Macmahon S, Mancia G, et al. 1999 World Health Organzation-International Society of Hypertension Guidelines for the management of hypertension. Guidelines subcommittee of the World Health Organization. Clin Exp Hypertens 1999;21(5-6):1009-60
   PubMed Web of Science ®Google Scholar
• Koopmans RP, Insel PA, Michel MC. Pharmacogenetics of hypertension treatment: a structured review. Pharmacogenetics 2003;13(12):705-713
   PubMedGoogle Scholar
• Striessnig J, Grabner M, Mitterdorfer J, et al. Structural basis of drug binding to Ca2+ channels. Trends Pharmacol Sci 1998;19(3):108-15
   PubMed Web of Science ®Google Scholar
• Poole PE. Anomalies in the dosing of Diltiazem. Clin Cardiol 2000;23(1):18-23
   Google Scholar
• Biovail Pharmaceuticals I: Cardizem-LA: Full Prescribing Information. In: Bridgewater, NJ; 92004
   Google Scholar
• Palma-Gamiz JL. High blood pressure and Calcium antagonist. Cardiology 1997;88 (Suppl 1):39-46
   PubMed Web of Science ®Google Scholar
• Cardiovascular Drug Therapy. Second edition. Messerli FH, editor. Philadelphia: Saunders; 1996
   Google Scholar
• Bighley LD, Dimmit DC, McGraw BF. Bioavailability of Diltiazem hydrochloride formulations. Clin Res 1980;28:587A
   Google Scholar
• Echizen H, Eichelbaum M. Clinical Pharmacokinetics of Verapamil, Nifedipine and Diltiazem. A reappraisal of its pharmacological properties and therapeutic use. Drugs 1990;39(5):757-806
   PubMed Web of Science ®Google Scholar
• Buckley MM, Grant SM, Goa KL, et al. Diltiazem, a reappraisal of its pharmacological properties and therapeutic use. Drugs 1990;39(5):757-806
   PubMed Web of Science ®Google Scholar
• Hoglund P, Nilsson LG. Pharmacokinetics of Diltiazem and its metabolites after single and multiple dosing in healthy volunteers. Ther Drug Monit 1989;11(5):558-66
   PubMed Web of Science ®Google Scholar
• Yabana H, Nagao T, Sato M. Cardiovascular effects of the metabolites of Diltiazem in Dogs. J Cardiovasc Pharmacol 1985;7(1):152-7
   PubMed Web of Science ®Google Scholar
• Joyal M, Pieper J, Cremer K, et al. Pharmacodynaminc aspects of intravenous Diltiazem administration. Am Heart J 1986;111(1):54-61
   PubMed Web of Science ®Google Scholar
• Pozet N, Brazier JL, Aissa AH, et al. Pharmacokinetics of Diltiazem in severe renal failure. Eur J Clin Pharmacol 1983;24(5):635-8
   PubMed Web of Science ®Google Scholar
• Koiwaya Y. Nakamura M, Mitsutake A, et al. Increased exercise after oral Diltiazem, a Calcium antagonist in angina pectoris. Am. Heart J 1981;101(2):143-9
   PubMed Web of Science ®Google Scholar
• Poole PE, Seagren SC, Bonanno JA, et al. The treatment of exercise-inducible chronic stable angina with Diltiazem. Effect on treadmill exercise. Chest 1980;78(1 Suppl):234-8
   PubMed Web of Science ®Google Scholar
• Strauss WE, Mcintyre KM, Parisi AF, Shapiro W. Safety and efficacy of Diltiazem hydrochloride for the treatment of stable angina pectoris: report of a cooperative clinical trial. Am J Cardiol 1982;49(3):560-6
   PubMed Web of Science ®Google Scholar
• Valette H, Apoil E. Hemodynamic effects of Diltiazem in healthy volunteers. Br J Clin Pharmacol 1980;10(6):623-4
   PubMed Web of Science ®Google Scholar
• Trimarco B, Deluca N, Ricciiardelli B, et al. Diltiazem in the treatment of mild or moderate essential hypertension. Comparison with Metoprolol in a crossover double-blind trial. J Clin Pharmacol 1984;24(5-6):218-27
   PubMed Web of Science ®Google Scholar
• Ogawa K, Ban M, Ito T, et al. Diltiazem for the treatment of essential hypertension: a double-blind controlled study with Reserpine. Clin Ther 1984;6(6):844-53
   PubMed Web of Science ®Google Scholar
• Pool PE, Massie BM, Venkataraman K, et al. Diltiazem as a monotherapy for systemic hypertension: a multicenter, randomized, placebo-controlled trial. Am J Cardiol 1986;57(4):212-7
   PubMed Web of Science ®Google Scholar
• Weir MR. Diltiazem: ten years of clinical experience in the treatment of hypertension. J Clin Pharmacol 1995;35(3):220-32
   PubMed Web of Science ®Google Scholar
• Ginsberg D, Pappas JE, Rofman BA, et al. Once-daily dosing of sustained-release Diltiazem capsules in mild-to-moderate hypertension. J Am Osteopath Assoc 1988;88(12):1489-92
   PubMed Web of Science ®Google Scholar
• Mooser V, Waeber B, Nussberger J, Brunner HR. Antihypertensive effect of Diltiazem administered once nad twice daily. J Hum Hypertens 1988;2(4):257-60
   PubMed Web of Science ®Google Scholar
• Felicetta JV, Serfer HM, Cutler NR, et al. A dose-response trial of once-daily Diltiazem. Am Heart J 1992;123(4 Pt 1):1022-6.
   PubMed Web of Science ®Google Scholar
• Massie BM, Der E, Herman TS, et al. 24-hour efficacy of once-daily Diltiazem in essential hypertension. Clin Cardiol 1992;15(5):365-8
   PubMed Web of Science ®Google Scholar
• Glasser SP, Gana TJ, Pascual LG. Efficacy and safety of once-daily graded-release Diltiazem HCl formulation dosed at bedtime (10pm) compared to placebo and to morning dosing (8am) in chronic stable angina pectoris (poster). Presented at 2003 American College of Cardiology (ACC) Annual Meeting, March 30 – April 2, 2003, Chicago, IL
   Google Scholar
• Glasser SP, Neutel JM, Gana TJ, Albert KS. Efficacy and safety of a once daily graded-release Diltiazem formulation in essential hypertension. Am J Hypertens 2003;16(1):51-8
   PubMed Web of Science ®Google Scholar
• White WB, Lacourciere Y, Gana T, et al. Effects of graded-release Diltiazem versus Ramipril, dosed at bedtime, on early morning blood pressure, heart rate and the rate-pressure product. Am. Heart J 2004;148(4):628-34
   PubMed Web of Science ®Google Scholar
• Wright JT Jr, Sica DA, Gana TJ. Antihypertensive efficacy of night time graded-release Diltiazem versus morning Amlodopine in African-Americans. Am J Hypertens 2004;17(9):734-42
   PubMed Web of Science ®Google Scholar
• Prognostic Value of Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy in Relation to Risk (the MAPEC Study). Available from: http://www.clinicaltrials.gov/ct2/show/NCT00295542?term=MAPEC+Study&rank=1
   Google Scholar